Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Bacterial Diversity Study Using 16S rRNA Sequencing of Periodontal Samples From Patients With Orthodontic Retainers (Ortho-Perio)

maanantai 27. heinäkuuta 2026 päivittänyt: Universidad de Murcia

After completion of orthodontic treatment, a retention phase is required to prevent relapse of tooth malposition. Fixed retention in the mandibular anterior region is commonly used. This type of retainer is bonded to the lingual surfaces of the canines and incisors and may hinder oral hygiene, thereby promoting bacterial plaque accumulation and gingival inflammation.

Currently, probably due to the increasing use of clear aligner therapy, clear removable Essix-type retainers are becoming more widely used. Since these retainers can be removed by the patient, they may facilitate oral hygiene. However, studies assessing gingival health and the composition of the subgingival microbiota in patients wearing orthodontic retainers remain scarce.

Therefore, the aim of this study will be to assess the composition of the gingival sulcus microbiota and gingival health in patients wearing fixed or removable orthodontic retainers.

Ten adult patients who have completed orthodontic treatment will be recruited and divided into two groups:

  1. Fixed retention group.
  2. Removable retention group.

Periodontal parameters will be assessed, and bacterial plaque samples will be collected from the gingival sulcus at five time points:

T0: Bracket removal and dental scaling appointment. Periodontal parameters will be assessed, and plaque samples will be collected before bracket debonding and dental scaling.

T1: Retainer placement appointment, three days after T0. Periodontal parameters will be assessed, and plaque samples will be collected before retainer placement.

T2: One month after retainer placement.

T3: Three months after retainer placement.

T4: Six months after retainer placement.

Tutkimuksen yleiskatsaus

Yksityiskohtainen kuvaus

The objectives of this study are:

  1. To compare the gingival sulcus microbiota in patients wearing fixed versus removable orthodontic retainers.
  2. To compare periodontal health in patients wearing fixed versus removable orthodontic retainers.

This prospective interventional comparative study will evaluate changes in gingival health and in the subgingival microbiota of adult patients following completion of orthodontic treatment with fixed multibracket appliances.

Ten participants attending the University Dental Clinic will be assigned to one of two retention groups: a fixed mandibular retainer group or a removable Essix-type retainer group.

Participants in the fixed retention group will receive a lingual retainer bonded from the mandibular left canine to the mandibular right canine, corresponding to teeth 33 to 43 according to the FDI tooth-numbering system. The same type of wire and bonding material will be used for all participants in this group.

Participants in the removable retention group will receive a clear Essix-type retainer manufactured using the same material and by the same dental technician. Participants will be instructed to wear the retainer for 22 hours per day.

To standardize oral hygiene procedures, all participants will receive the same oral hygiene instructions and an oral hygiene kit for use throughout the study period.

Clinical periodontal assessments and subgingival plaque sampling will be performed at five study visits:

T0: On the day of bracket removal and dental scaling. Periodontal assessments and plaque sampling will be performed before bracket debonding and scaling.

T1: Three days after T0, immediately before retainer placement.

T2: One month after retainer placement.

T3: Three months after retainer placement.

T4: Six months after retainer placement.

At each visit, periodontal health will be evaluated using plaque accumulation, bleeding on probing, probing pocket depth, clinical attachment level, and gingival recession.

Subgingival plaque samples will be collected from the mandibular anterior region using sterile paper points. Sampling will be performed at the mesial surface of each mandibular canine and at the mesial and distal surfaces of each mandibular incisor. The gingival tissue will be gently displaced to allow insertion of the paper point into the gingival sulcus without bending or contaminating the sample.

After collection, the portion of the paper point inserted into the gingival sulcus will be placed in an Eppendorf tube containing sterile phosphate-buffered saline. Samples will be stored at -22 °C until microbiological analysis.

The bacterial composition of the samples will be assessed using 16S ribosomal RNA gene sequencing. Changes in microbiota composition and periodontal parameters over time will be compared between the fixed and removable retention groups.

Participants will be instructed not to eat, drink, brush their teeth, or use mouthwash for at least two hours before each plaque-sampling visit.

Opintotyyppi

Interventio

Ilmoittautuminen (Arvioitu)

10

Vaihe

  • Ei sovellettavissa

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskeluyhteys

  • Nimi: Ascensión Vicente, DDS PhD
  • Puhelinnumero: +3486888664
  • Sähköposti: ascenvi@um.es

Opiskelupaikat

      • Murcia, Espanja, 30008
        • Rekrytointi
        • University Dental Clinic
        • Ottaa yhteyttä:
          • Ascensión Vicente, DDS PhD
          • Puhelinnumero: +34868888664
          • Sähköposti: ascenvi@um.es

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

  • Aikuinen

Hyväksyy terveitä vapaaehtoisia

Ei

Kuvaus

Inclusion Criteria:

  • Treatment involving both dental arches
  • Permanent dentition with at least 24 teeth
  • Treatment duration longer than 12 months
  • Treatment using the Versatile MBT system with a 0.022-inch slot

Exclusion Criteria:

  • Patients with systemic disease or taking medications that may affect periodontal health
  • Inadequate restorations or active carious lesions
  • iodontal disease
  • Plaque index greater than 20% before placement of the retainer or during the study
  • Use of oral antiseptics within the previous 6 months or during the study period
  • Use of antibiotics within the previous 14 days or during the study period
  • Smokers
  • Pregnant or breastfeeding women
  • Presence of open gingival embrasures, crowding, or dental malposition in the mandibular anterior region after orthodontic treatment

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Ensisijainen käyttötarkoitus: Muut
  • Jako: Ei satunnaistettu
  • Inventiomalli: Rinnakkaistehtävä
  • Naamiointi: Yksittäinen

Aseet ja interventiot

Osallistujaryhmä / Arm
Interventio / Hoito
Active Comparator: Fixed Orthodontic Retention
Participants assigned to this arm will receive a fixed lingual orthodontic retainer bonded to the mandibular anterior teeth, extending from tooth 33 to tooth 43. The same retainer wire and bonding materials will be used for all participants
A fixed lingual orthodontic retainer bonded to the mandibular anterior teeth, extending from tooth 33 to tooth 43
Kokeellinen: Removable Essix-Type Orthodontic Retention
Participants assigned to this arm will receive a clear removable Essix-type orthodontic retainer. Participants will be instructed to wear the retainer for 22 hours per day. All retainers will be manufactured using the same material and by the same dental technician.
A clear removable Essix-type orthodontic retainer prescribed for 22 hours of daily wear

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Longitudinal change in subgingival microbial community composition assessed using Bray-Curtis dissimilarity
Aikaikkuna: T0: pre-debonding; T1: pre-retainer baseline, 3 days after T0; T2: 1 month post-retainer; T3: 3 months post-retainer; T4: 6 months post-retainer.
Subgingival plaque samples collected from the mandibular anterior teeth will be analyzed using 16S rRNA gene sequencing. Overall microbial community composition will be assessed using the Bray-Curtis dissimilarity index. Longitudinal differences in microbial community composition will be evaluated between participants receiving fixed orthodontic retainers and those receiving removable Essix retainers, considering the effect of study group, assessment time point, and their interaction.
T0: pre-debonding; T1: pre-retainer baseline, 3 days after T0; T2: 1 month post-retainer; T3: 3 months post-retainer; T4: 6 months post-retainer.
Longitudinal change in bleeding on probing
Aikaikkuna: T0: pre-debonding; T1: pre-retainer baseline, 3 days after T0; T2: 1 month post-retainer; T3: 3 months post-retainer; T4: 6 months post-retainer.
Bleeding on probing will be recorded as present or absent at six sites per tooth in the mandibular anterior region following gentle periodontal probing. The outcome will be calculated as the percentage of examined sites showing bleeding for each participant. Longitudinal changes in bleeding on probing will be compared between participants receiving fixed orthodontic retainers and those receiving removable Essix retainers, considering the effect of study group, assessment time point, and their interaction.
T0: pre-debonding; T1: pre-retainer baseline, 3 days after T0; T2: 1 month post-retainer; T3: 3 months post-retainer; T4: 6 months post-retainer.

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Longitudinal change in subgingival microbial alpha diversity assessed using the Shannon diversity index
Aikaikkuna: T0: pre-debonding; T1: pre-retainer baseline, 3 days after T0; T2: 1 month post-retainer; T3: 3 months post-retainer; T4: 6 months post-retainer.

Subgingival plaque samples collected from the mandibular anterior teeth will be analyzed using 16S rRNA gene sequencing. Alpha diversity will be quantified using the Shannon diversity index for each sample. Higher values indicate greater microbial diversity within the sample. Longitudinal changes will be compared between participants receiving fixed orthodontic retainers and those receiving removable Essix retainers, considering study group, assessment time point, and their interaction.

Time Frame

T0: pre-debonding; T1: pre-retainer baseline, 3 days after T0; T2: 1 month post-retainer; T3: 3 months post-retainer; T4: 6 months post-retainer.
Longitudinal change in subgingival microbial evenness assessed using Pielou's evenness index
Aikaikkuna: T0: pre-debonding; T1: pre-retainer baseline, 3 days after T0; T2: 1 month post-retainer; T3: 3 months post-retainer; T4: 6 months post-retainer.
Microbial community evenness will be quantified using Pielou's evenness index calculated from the 16S rRNA gene sequencing data. The index ranges from 0 to 1, with higher values indicating a more even distribution of bacterial taxa within the microbial community. Longitudinal changes will be compared between the fixed-retainer and removable-retainer groups across all study visits.
T0: pre-debonding; T1: pre-retainer baseline, 3 days after T0; T2: 1 month post-retainer; T3: 3 months post-retainer; T4: 6 months post-retainer.
Longitudinal change in subgingival microbial dominance assessed using the Simpson dominance index
Aikaikkuna: T0: pre-debonding; T1: pre-retainer baseline, 3 days after T0; T2: 1 month post-retainer; T3: 3 months post-retainer; T4: 6 months post-retainer.
Microbial dominance will be quantified using the Simpson dominance index calculated from the 16S rRNA gene sequencing data. Higher index values indicate greater dominance of the microbial community by a limited number of bacterial taxa. Longitudinal changes will be compared between participants receiving fixed orthodontic retainers and those receiving removable Essix retainers across all study visits.
T0: pre-debonding; T1: pre-retainer baseline, 3 days after T0; T2: 1 month post-retainer; T3: 3 months post-retainer; T4: 6 months post-retainer.
Longitudinal change in subgingival microbial taxonomic composition
Aikaikkuna: T0: pre-debonding; T1: pre-retainer baseline, 3 days after T0; T2: 1 month post-retainer; T3: 3 months post-retainer; T4: 6 months post-retainer.
The relative abundance of bacterial taxa identified by 16S rRNA gene sequencing will be calculated as the percentage of sequencing reads assigned to each taxon. Taxonomic composition will be evaluated at the phylum, family, and genus levels and, where technically feasible, at the species level. Longitudinal changes will be compared between participants receiving fixed orthodontic retainers and those receiving removable Essix retainers.
T0: pre-debonding; T1: pre-retainer baseline, 3 days after T0; T2: 1 month post-retainer; T3: 3 months post-retainer; T4: 6 months post-retainer.
Differential abundance of subgingival bacterial taxa
Aikaikkuna: T0: pre-debonding; T1: pre-retainer baseline, 3 days after T0; T2: 1 month post-retainer; T3: 3 months post-retainer; T4: 6 months post-retainer.
Differential abundance analysis will be performed using 16S rRNA gene sequencing data to identify bacterial taxa whose abundance differs between participants receiving fixed orthodontic retainers and those receiving removable Essix retainers, as well as taxa showing changes over time within each group. Correction for multiple comparisons will be applied.
T0: pre-debonding; T1: pre-retainer baseline, 3 days after T0; T2: 1 month post-retainer; T3: 3 months post-retainer; T4: 6 months post-retainer.
Longitudinal change in plaque index
Aikaikkuna: T0: pre-debonding; T1: pre-retainer baseline, 3 days after T0; T2: 1 month post-retainer; T3: 3 months post-retainer; T4: 6 months post-retainer.
The presence or absence of dental plaque will be recorded at six surfaces per tooth in the mandibular anterior region: three buccal surfaces and three lingual surfaces. The plaque index will be calculated for each participant as the percentage of examined surfaces showing detectable plaque. Longitudinal changes will be compared between participants receiving fixed orthodontic retainers and those receiving removable Essix retainers.
T0: pre-debonding; T1: pre-retainer baseline, 3 days after T0; T2: 1 month post-retainer; T3: 3 months post-retainer; T4: 6 months post-retainer.
Longitudinal change in periodontal probing depth
Aikaikkuna: T0: pre-debonding; T1: pre-retainer baseline, 3 days after T0; T2: 1 month post-retainer; T3: 3 months post-retainer; T4: 6 months post-retainer.
Periodontal probing depth will be measured in millimeters from the gingival margin to the base of the gingival sulcus or periodontal pocket using a periodontal probe. Measurements will be recorded at six sites per tooth in the mandibular anterior region. The mean probing depth will be calculated for each participant, and longitudinal changes will be compared between study groups.
T0: pre-debonding; T1: pre-retainer baseline, 3 days after T0; T2: 1 month post-retainer; T3: 3 months post-retainer; T4: 6 months post-retainer.
Longitudinal change in clinical attachment level
Aikaikkuna: T0: pre-debonding; T1: pre-retainer baseline, 3 days after T0; T2: 1 month post-retainer; T3: 3 months post-retainer; T4: 6 months post-retainer.
Clinical attachment level will be measured in millimeters from the cementoenamel junction to the base of the gingival sulcus or periodontal pocket. Measurements will be recorded at six sites per tooth in the mandibular anterior region. The mean clinical attachment level will be calculated for each participant, and longitudinal changes will be compared between study groups.
T0: pre-debonding; T1: pre-retainer baseline, 3 days after T0; T2: 1 month post-retainer; T3: 3 months post-retainer; T4: 6 months post-retainer.
Longitudinal change in gingival recession
Aikaikkuna: T0: pre-debonding; T1: pre-retainer baseline, 3 days after T0; T2: 1 month post-retainer; T3: 3 months post-retainer; T4: 6 months post-retainer.
Gingival recession will be measured in millimeters from the cementoenamel junction to the gingival margin when the gingival margin is located apical to the cementoenamel junction. Measurements will be recorded at six sites per tooth in the mandibular anterior region. The mean gingival recession will be calculated for each participant, and longitudinal changes will be compared between study groups.
T0: pre-debonding; T1: pre-retainer baseline, 3 days after T0; T2: 1 month post-retainer; T3: 3 months post-retainer; T4: 6 months post-retainer.

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Tutkijat

  • Opintojen puheenjohtaja: Antonio J Ortiz Ruiz, MD PhD, Universidad de Murcia

Julkaisuja ja hyödyllisiä linkkejä

Tutkimusta koskevien tietojen syöttämisestä vastaava henkilö toimittaa nämä julkaisut vapaaehtoisesti. Nämä voivat koskea mitä tahansa tutkimukseen liittyvää.

Yleiset julkaisut

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Todellinen)

Maanantai 12. tammikuuta 2026

Ensisijainen valmistuminen (Arvioitu)

Torstai 1. heinäkuuta 2027

Opintojen valmistuminen (Arvioitu)

Torstai 1. heinäkuuta 2027

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Torstai 16. heinäkuuta 2026

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Torstai 16. heinäkuuta 2026

Ensimmäinen Lähetetty (Todellinen)

Tiistai 21. heinäkuuta 2026

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Tiistai 28. heinäkuuta 2026

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Maanantai 27. heinäkuuta 2026

Viimeksi vahvistettu

Keskiviikko 1. heinäkuuta 2026

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Yksittäisten osallistujien tietojen suunnitelma (IPD)

Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?

PÄÄTTÄMÄTÖN

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Ei

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa